title: Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
authors.forename: Christina L
authors.initials: CL
authors.lastname: Rim
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Gitlin
mesh_terms: D000328:Adult; D003865:Major Depressive Disorder / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D020230:Serotonin Syndrome / Q000139:chemically induced*; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014191:Tranylcypromine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D008996:Monoamine Oxidase Inhibitors; D010879:Piperazines; D012702:Serotonin Antagonists; D013844:Thiazoles; D014191:Tranylcypromine; C092292:ziprasidone